1 ncurrently with neoadjuvant chemotherapy and continued after surgery).
2 chorionic gonadotropin and alfa-fetoprotein continued BEP (Fav-BEP group) for 3 additonal cycles, wh
3 vaccine-preventable diseases has been made, continued cases and outbreaks of these diseases persist,
4 e inside of the septal ring while permitting continued constriction of the outside portion.
5 quality for its own sake but for the sake of continued cooperation.
6 asing agricultural importance because of the continuing depletion of the rock phosphate reserves that
7 There also remain continued disincentives for firms to measure and pay the
8 Continued evaluation of these technologies with large, w
9 Our results suggest that a continued gradual decline of photosynthetic capacity and
10 Endocycles are well known for enabling continued growth of post-mitotic tissues.
11 However, continued IFN-alpha2a treatment induced IFN-I desensitiz
12 terns of population weight gain will lead to continuing increases in the future burden of cancer.
13 at as occurring after meltwater pulse 1A and continuing into the late Holocene epoch.
14 Moreover, the results suggest that continued optimization should be possible, and that the
15 Thus, there is an urgent need for continued research into the epidemiology, pathogenesis,
16 tained community engagement and empowerment, continued research, political will, structural and polic
17 beginning in the late 1800s, a process that continued throughout the twentieth century and up to the
18 The established treatments for hyperopia continue to accumulate evidence supporting their safety
19 um leprae, is still occurring, and new cases continue to appear.
20 The lives of most people with epilepsy continue to be adversely affected by gaps in knowledge,
21 ammalian target of rapamycin (mTOR) pathways continue to be the mainstay for treating metastatic RCC
22 ppression regimens for transplant recipients continue to be the subject of ongoing investigation.
23 Surgical techniques continue to change and improve outcomes.
24 ally long wait list times.Rates of rejection continue to decline in both fields as immunosuppression
25 and Crimean-Congo haemorrhagic fever viruses continue to emerge in new geographical locations.
26 eatment strategies for early-stage seminomas continue to evolve toward surveillance versus chemothera
27 roviding sustained drug delivery in glaucoma continue to evolve.
28 stem process, and the impact on society will continue to grow.
29 As such, culture and phylogeny will continue to have crucially important roles in human micr
30 Dengue epidemics continue to increase in frequency, geographic range, and
31 and DMEK, it is likely both procedures will continue to increase over time.
32 ng, but the associated high sequencing costs continue to limit its widespread application.
33 Resistant bacterial infections in humans continue to pose a significant challenge globally.
34 Apolipoprotein mimetic peptides continue to show efficacy in a number of animal models o
35 Recent studies continue to support that MRM is precipitated by drops in
36 In the extension study, levels of ALP continued to decrease to a mean level of 202 +/- 11 U/L
37 Imaging technology continues to advance as do approaches to in-utero interv
38 LOS continues to be an understudied area.
39 of bacterial sRNAs across different species continues to be puzzling, given that they can exert simi
40 ial imaging.The use of multimodal monitoring continues to be refined and it may be possible to use th
41 ic cell reprogramming to a pluripotent state continues to challenge many of our assumptions about cel
42 Although the field of research continues to expand, it is clear that many barriers rema
43 n cycle is not fully functional, but RubisCO continues to fix CO2 and synthesize 3-phosphoglycerate.
44 oma (MCL) is a mature B-cell malignancy that continues to have a high mortality rate.
45 ers, yet the population distribution clearly continues to maintain a two-cluster structure.
46 The high prevalence of childhood obesity continues to persist, especially in children and youth w
47 ul, programs seeking to expand access to and continued use of ART by integrating maternal health and
48 th probability 0.25) to pump treatment or to continue with multiple daily injections.
49 be reduced in adolescent women if clinicians continue with regular chlamydia screening in sexually ac
50 g with basic rational control techniques and continuing with advanced level modern approaches, we rev
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。